|
Re: Kick the can
|
1
|
Resverlogix Corp.
|
Aug 24, 2017 10:00PM
|
|
Re: Kick the can
|
2
|
Resverlogix Corp.
|
Aug 24, 2017 10:28PM
|
|
Re: Entertainment During Wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2017 03:24PM
|
|
Re: At least we closed up.....
|
1
|
Resverlogix Corp.
|
Aug 26, 2017 10:30AM
|
|
Re: While we wait, outside items that may be of interest
|
2
|
Resverlogix Corp.
|
Aug 27, 2017 11:11AM
|
|
Re: What credibility?
|
3
|
Resverlogix Corp.
|
Aug 27, 2017 04:37PM
|
|
Re: Wonderful
|
2
|
Resverlogix Corp.
|
Aug 28, 2017 11:58AM
|
|
Re: Wonderful
|
4
|
Resverlogix Corp.
|
Aug 28, 2017 08:48PM
|
|
Re: Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Aug 29, 2017 04:14PM
|
|
Re: Underwhelmed
|
1
|
Resverlogix Corp.
|
Aug 30, 2017 08:51AM
|
|
Re: Zenith cost basis
|
3
|
Zenith Epigenetics
|
Aug 30, 2017 04:49PM
|
|
Inflammation as a target
|
2
|
Resverlogix Corp.
|
Aug 31, 2017 10:50AM
|
|
Zenith Financials
|
4
|
Zenith Epigenetics
|
Aug 31, 2017 12:59PM
|
|
Re: China, China, China
|
7
|
Resverlogix Corp.
|
Aug 31, 2017 04:56PM
|
|
Re: China, China, China
|
2
|
Resverlogix Corp.
|
Aug 31, 2017 06:02PM
|
|
Re: China, China, China
|
2
|
Resverlogix Corp.
|
Aug 31, 2017 09:15PM
|
|
Re: Lot's to be excited about!
|
3
|
Resverlogix Corp.
|
Sep 01, 2017 02:13PM
|
|
GV and BoM
|
3
|
Resverlogix Corp.
|
Sep 01, 2017 05:20PM
|
|
post by F6 at IV re inflammation
|
1
|
Resverlogix Corp.
|
Sep 02, 2017 01:57PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Sep 02, 2017 02:06PM
|
